Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96177752 | 9617775 | 2 | F | 20130902 | 20131122 | 20131009 | 20131205 | EXP | VAL_02756_2013 | VALIDUS | 66.00 | YR | A | M | N | 76.00000 | KG | 20131204 | MD | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96177752 | 9617775 | 1 | PS | CIBACEN | BENAZEPRIL HYDROCHLORIDE | 1 | ORAL | Y | CN 2154 | 19851 | 10 | MG | QD | ||||||
| 96177752 | 9617775 | 3 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 5 | C | CARDIOASPIRIN | ASPIRIN | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 7 | C | CALCITRIOL. | CALCITRIOL | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 9 | C | CARVIPRESS | 2 | 0 | |||||||||||||
| 96177752 | 9617775 | 11 | C | LUCEN | ESOMEPRAZOLE | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 13 | C | MODURETIC 5-50 | AMILORIDE HYDROCHLORIDEHYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 15 | C | NOVONORM | REPAGLINIDE | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 17 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 19 | C | TORVAST | ATORVASTATIN | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 21 | C | ARICEPT | DONEPEZIL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 23 | C | TRIAZOLAM. | TRIAZOLAM | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 24 | C | VALDOXAN | AGOMELATINE | 1 | 0 | ||||||||||||
| 96177752 | 9617775 | 26 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96177752 | 9617775 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96177752 | 9617775 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96177752 | 9617775 | Condition aggravated | |
| 96177752 | 9617775 | Renal impairment | |
| 96177752 | 9617775 | Rib fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 96177752 | 9617775 | FGN |
| 96177752 | 9617775 | HP |
| 96177752 | 9617775 | SDY |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96177752 | 9617775 | 1 | 20070722 | 20130902 | 0 |